Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by jdstoxon Jun 17, 2020 12:35pm
203 Views
Post# 31160726

RE:High doses of Herceptin into the brain - Chemobrain

RE:High doses of Herceptin into the brain - ChemobrainWell, there you go again, digitel. You're a regular ray of sunshine.

So, do you have so little faith in the capabilities of oncologists that you believe they wouldn't know how to start with low dosages and ramp them up as brain tumours are shrunk and eliminated?

Do you really think they wouldn't know how to do that?

If Bioasis hands a brain tumour treatment to oncologists, my guess is that they'll figure out how to safely use it.

So what happened? Have you sold all your shares and now need to drive the share price back so you can buy and flip some more? Is that why you're promoting weakness in this nice little run we're having?

You're about as smooth as stucco, digitel. As subtle as a hand grenade in a pot of porridge.

Bullboard Posts